Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by LTOWNERon Apr 02, 2014 12:36pm
256 Views
Post# 22400694

RE:RE:CV risk study is "sloppy"

RE:RE:CV risk study is "sloppy"Heaven help us if the statin comment is correct.  I just finished reading today’s Dr, Mercola article saying Cholesterol-lowering statin drugs are among the most widely prescribed drugs on the market, with one in four Americans over 45 taking them. This already inflated number is set to increase significantly, however, courtesy of controversial revised cholesterol-treatment guidelines issued by the American Heart Association (AHA) and the American College of Cardiology (ACC) last year.”  Under latest guidelines “half of older adults should take statins.”
 
 
One study found the following: “When they compared men on statins to those not, the men on statins were twice as likely to have low testosterone, regardless of which of three commonly used thresholds for low testosterone they looked at.  The researchers emphasize they have found a link, not a cause and effect, between statins and lower testosterone. They can't explain the link with certainty.  One possibility is that low testosterone levels and the need for statin treatment share some common causes.  Some researchers also have looked at the possibility that the statins' inhibition of cholesterol synthesis may interfere with the production of testosterone, which depends on a supply of cholesterol. The statins may disrupt the body's feedback mechanism to instruct it to make more testosterone.”
https://www.webmd.com/erectile-dysfunction/news/20100416/statins_may_lower_testosterone_libido

This may explain a friend of mine who was telling me last summer he went on statins and was totally miserable – depressed, cranky & zero libido.  He stopped and his life turned back around.
Bullboard Posts